Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CNCR vs. VOO: which is better?

Bottom line

CNCR vs VOO: the short answer

CNCR (Range Cancer Therapeutics ETF) and VOO (Vanguard 500 Index Fund) are both etfs.

Updated Nov 19, 2026

CNCR vs VOO side by side

CNCRVOO
TypeETFETF
Fund familyGrayscaleVanguard
CategoryOtherS&P 500 Index
Expense ratio—0.03%
Annual cost per $10k—$3
10-yr cost on $10k (prospectus)—$39
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+17.8%
5-yr return (annualized)—+14.4%
10-yr return (annualized)—+14.8%
Best quarter—+20.5%
Worst quarter—−19.6%
Net assets (fund)—$1.7T
Number of holdings—520
Portfolio turnover—2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CNCR and VOO share none of their top holdings.

CNCR top 10

    VOO top 10

    1. NVIDIA Corp — 7.51%
    2. Apple Inc — 6.59%
    3. Microsoft Corp — 4.30%
    4. Amazon.com Inc — 3.62%
    5. Alphabet Inc — 3.25%
    6. Broadcom Inc — 2.77%
    7. Alphabet Inc — 2.59%
    8. Micron Technology Inc — 2.02%
    9. Meta Platforms Inc — 1.92%
    10. Tesla Inc — 1.84%

    FAQ

    What is the difference between CNCR and VOO?
    CNCR (Range Cancer Therapeutics ETF) and VOO (Vanguard 500 Index Fund) are both etfs.
    Should I own both CNCR and VOO?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.